About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT04115215

Pre-FRONTal Brain STability, Key for Action Against Disability in AGing

Cognitive and mobility impairments are critical contributors to dementia and disability in older adults, and can be caused by neurodegenerative and neurovascular changes at the pre-frontal (PF) brain ...

Lead sponsor: Parc Sanitari Pere Virgili•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Parc Sanitari Pere Virgili

Collaborators

Institute for Photonic Sciences - ICFO
Hospital de la Ribera
Fundacio Ictus Malaltia Vascular
Institut Català de la Salut
Vall d'Hebron Institute Research

Age

65 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. older adults (65 years or older)
•2. with Motoric Cognitive Risk Syndrome
•3. characterized by impaired cognition (which in our case will be confirmed with a Spanish version of the Montreal cognitive Assessment (MOCA), score between 26 and 21)
•4. mobility impairment (measured as slow gait speed\<0.8 m/s)
•5. without diagnosed clinical neurological or psychiatric diseases
•6. with a preserved functional status for the activities of daily living
•7. who can walk without help from third parties

Exclusion Criteria

•1. a diagnosis of dementia
•2. advanced/terminal disease (life expectancy\<1 year)
•3. contraindications to exercise and tCS
•4. unwilling to give informed consent

Related studies

Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

NCT06347315 · Mild Cognitive Impairment

rTMS Combined With Aerobic Exercise for Older Adults With Mild Cognitive Impairment and Comorbid Depression

NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms

Figure-of-8 Walk Test in Individuals With Motoric Cognitive Risk Syndrome

NCT07586553 · Motoric Cognitive Risk Syndrome, Gait, and more

Laser-Based Map Tests in Motoric Cognitive Risk Syndrome

NCT07572942 · Motoric Cognitive Risk Syndrome, Cognitive-Motor Interaction, and more

A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 2, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment93

Start dateMar 2020

Last updatedJul 2, 2021

Condition

Cognitive Impairment Motoric Cognitive Risk Syndrome

Locations shown

The Institute of Photonic Sciences (ICFO)

Castelldefels, Barcelona

Hospital Universitario La Ribera

Alzira, Valencia

Institut Català de la Salut

Barcelona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 2, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions